clinical trial · NCT04358146
Study on the Efficacy and Tolerance of a New Anti-regurgitation Infant Formula (STELLAR)
Gastroesophageal Reflux in ChildrenExperimental Infant formulaInfant formula thickened with locust bean gum
brief summary
The aim of the study is to assess the effectiveness of this new formula on regurgitations and secondarily its effect on digestive tolerance through a randomized, controlled, double-blind trial against a comparator.
started
Mar 17, 2023
primary completion
Dec 3, 2026
completion
Dec 3, 2026
last updated
May 4, 2026
detailed description
The study duration is 1 month and 2 days. It is possible to add 2 additional months (optional).
The 2 first days (from D-3 to D0) correspond to the pre-selection period. These 2 days are followed by the follow-up month (from D0 to D30). It is possible to add an optional follow up of 2 months (form D30 to D90).
official title
Study on the Efficacy and Tolerance of a New Anti-regurgitation Infant Formula: a Double-blind, Randomized, Controlled, International, Multi-centric Clinical Trial
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol